Yakubogullari N, Cagir A, Bedir E, Sag D
Vaccines (Basel). 2023; 11(3).
PMID: 36992079
PMC: 10059926.
DOI: 10.3390/vaccines11030495.
Li W, Syed F, Yu R, Yang J, Xia Y, Relich R
Front Immunol. 2022; 13:833310.
PMID: 35281051
PMC: 8904355.
DOI: 10.3389/fimmu.2022.833310.
Deimel L, Li Z, Roy S, Ranasinghe C
Sci Rep. 2021; 11(1):10495.
PMID: 34006897
PMC: 8131749.
DOI: 10.1038/s41598-021-89860-7.
Barros P, Berthoud T, Aloufi N, Angel J
Immunotargets Ther. 2021; 10:47-62.
PMID: 33728276
PMC: 7954429.
DOI: 10.2147/ITT.S264149.
George P, Hess J, Jain S, Patton J, Zhan T, Tricoche N
PLoS Negl Trop Dis. 2019; 13(9):e0007730.
PMID: 31525197
PMC: 6762197.
DOI: 10.1371/journal.pntd.0007730.
The role of soluble common gamma chain in autoimmune disease.
Lee B, Hong C
Anat Cell Biol. 2015; 48(1):10-5.
PMID: 25806117
PMC: 4371176.
DOI: 10.5115/acb.2015.48.1.10.
IL12Rβ1ΔTM is a secreted product of il12rb1 that promotes control of extrapulmonary tuberculosis.
Ray A, Fountain J, Miller H, Cooper A, Robinson R
Infect Immun. 2014; 83(2):560-71.
PMID: 25404030
PMC: 4294230.
DOI: 10.1128/IAI.01230-13.
Altered gamma-aminobutyric acid type B receptor subunit 1 splicing in alcoholics.
Lee C, Mayfield R, Harris R
Biol Psychiatry. 2013; 75(10):765-73.
PMID: 24209778
PMC: 3999301.
DOI: 10.1016/j.biopsych.2013.08.028.
A molecular perspective on TH2-promoting cytokine receptors in patients with allergic disease.
Romeo M, Agrawal R, Pomes A, Woodfolk J
J Allergy Clin Immunol. 2013; 133(4):952-60.
PMID: 24084078
PMC: 3969406.
DOI: 10.1016/j.jaci.2013.08.006.
Comparison of drug and cell-based delivery: engineered adult mesenchymal stem cells expressing soluble tumor necrosis factor receptor II prevent arthritis in mouse and rat animal models.
Liu L, Wang G, Hendricks K, Lee K, Bohnlein E, Junker U
Stem Cells Transl Med. 2013; 2(5):362-75.
PMID: 23592838
PMC: 3667563.
DOI: 10.5966/sctm.2012-0135.
Selective stimulation of IL-4 receptor on smooth muscle induces airway hyperresponsiveness in mice.
Perkins C, Yanase N, Smulian G, Gildea L, Orekov T, Potter C
J Exp Med. 2011; 208(4):853-67.
PMID: 21464224
PMC: 3135339.
DOI: 10.1084/jem.20100023.
Intron 4 containing novel GABAB1 isoforms impair GABAB receptor function.
Lee C, Mayfield R, Harris R
PLoS One. 2010; 5(11):e14044.
PMID: 21124972
PMC: 2987798.
DOI: 10.1371/journal.pone.0014044.
Diversifying selection and functional analysis of interleukin-4 suggests antagonism-driven evolution at receptor-binding interfaces.
Koyanagi M, Kerns J, Chung L, Zhang Y, Brown S, Moldoveanu T
BMC Evol Biol. 2010; 10:223.
PMID: 20649995
PMC: 3017759.
DOI: 10.1186/1471-2148-10-223.
Immunotherapy for allergies and asthma: present and future.
Mohapatra S, Qazi M, Hellermann G
Curr Opin Pharmacol. 2010; 10(3):276-88.
PMID: 20573547
PMC: 2915930.
DOI: 10.1016/j.coph.2010.05.012.
Suppression subtractive hybridization analysis of low-protein diet- and vitamin D-induced gene expression from rat kidney inner medullary base.
Chen G, Yang Y, Frohlich O, Klein J, Sands J
Physiol Genomics. 2010; 41(3):203-11.
PMID: 20197420
PMC: 2869109.
DOI: 10.1152/physiolgenomics.00129.2009.
Differential regulation of IL-4Ralpha expression by antigen versus cytokine stimulation characterizes Th2 progression in vivo.
Perona-Wright G, Mohrs K, Mayer K, Mohrs M
J Immunol. 2009; 184(2):615-23.
PMID: 20018622
PMC: 3066071.
DOI: 10.4049/jimmunol.0902408.
Pathogenicity of a disease-associated human IL-4 receptor allele in experimental asthma.
Tachdjian R, Mathias C, Al Khatib S, Bryce P, Kim H, Blaeser F
J Exp Med. 2009; 206(10):2191-204.
PMID: 19770271
PMC: 2757875.
DOI: 10.1084/jem.20091480.
Structural biology of shared cytokine receptors.
Wang X, Lupardus P, LaPorte S, Garcia K
Annu Rev Immunol. 2008; 27:29-60.
PMID: 18817510
PMC: 3981547.
DOI: 10.1146/annurev.immunol.24.021605.090616.
The sushi domains of secreted GABA(B1) isoforms selectively impair GABA(B) heteroreceptor function.
Tiao J, Bradaia A, Biermann B, Kaupmann K, Metz M, Haller C
J Biol Chem. 2008; 283(45):31005-11.
PMID: 18765663
PMC: 2576543.
DOI: 10.1074/jbc.M804464200.
Interleukin-4 (IL-4) enhances and soluble interleukin-4 receptor (sIL-4R) inhibits histamine release from peripheral blood basophils and mast cells in vitro and in vivo.
Niggemann B, Zuberbier T, Herz U, Enssle K, Wahn U, Renz H
Mediators Inflamm. 1997; 6(2):111-8.
PMID: 18472844
PMC: 2365851.
DOI: 10.1080/09629359791802.